Prot # B5301001: A Phase 2, Randomized, Double-Blind, Within-Subject, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PF-06473871 in Reducing Hypertrophic Skin Scarring

Project: Research project

Project Details

StatusFinished
Effective start/end date7/18/137/18/16

Funding

  • PRA Health Sciences (Protocol # B5301001)
  • Pfizer Inc. (Protocol # B5301001)